Anti-Transcriptional Intermediary Factor 1-gamma Antibodies in Dermatomyositis with and Without Cancer - A Longitudinal Study

被引：0
|
作者：
Dani, Lara [1 ,2 ]
Selickaja, Sandra [3 ,4 ]
Galindo-Feria, Angeles Shunashy [5 ]
Svensson, John [1 ]
Venalis, Paulius [6 ]
Leonard, Dag [7 ]
Hemberg, Malin [8 ]
Hanna, Balsam [9 ]
Lundberg, Ingrid E. [10 ]
Holmqvist, Marie [1 ]
机构：
[1] Karolinska Inst, Stockholm, Sweden
[2] Karolinska Univ Hosp, Stockholm, Sweden
[3] State Res Inst Innovat Med, Vilnius, Lithuania
[4] Vilnius Univ Hosp, Santaros Klin, Vilnius, Lithuania
[5] Karolinska Inst, Karolinska Univ Hosp, Stockholm, Sweden
[6] Karolinska Inst, Dept Med, Ctr Mol Med, Stockholm, Sweden
[7] Uppsala Univ, Dept Rheumatol, Uppsala, Sweden
[8] Falu Lasarett, Rheumatol Unit, Falun, Sweden
[9] Sahlgrens Univ Hosp, Dept Rheumatol, Gothenburg, Sweden
[10] Karolinska Inst, Karolinska Univ Hosp, Div Rheumatol, Dept Med Solna, Stockholm, Sweden
来源：
ARTHRITIS & RHEUMATOLOGY | 2021年 / 73卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0696
引用
收藏
页码：1412 / 1413
页数：2
相关论文
共 50 条
  • [21] A patient with Parkinson’s disease and dermatomyositis with serum anti-transcriptional intermediary factor 1-γ antibody
    Chiaki Murase
    Yoshinao Muro
    Hirotaka Nakanishi
    Masahisa Katsuno
    Masashi Akiyama
    European Journal of Dermatology, 2016, 26 : 617 - 618
  • [22] Clinical significance of serum levels of anti-transcriptional intermediary factor 1-γ antibody in patients with dermatomyositis
    Ikeda, Nobuaki
    Yamaguchi, Yukie
    Kanaoka, Miwa
    Ototake, Yasushi
    Akita, Asami
    Watanabe, Tomoya
    Aihara, Michiko
    JOURNAL OF DERMATOLOGY, 2020, 47 (05): : 490 - 496
  • [23] A patient with Parkinson's disease and dermatomyositis with serum anti-transcriptional intermediary factor 1-γ antibody
    Murase, Chiaki
    Muro, Yoshinao
    Nakanishi, Hirotaka
    Katsuno, Masahisa
    Akiyama, Masashi
    EUROPEAN JOURNAL OF DERMATOLOGY, 2016, 26 (06) : 617 - 618
  • [24] Use of Anti-transcriptional Intermediary Factor-1 Gamma Autoantibody in Identifying Adult Dermatomyositis Patients with Cancer: A Systematic Review and Meta-analysis
    Best, Marion
    Molinari, Nicolas
    Chasset, Francois
    Vincent, Thierry
    Cordel, Nadege
    Bessis, Didier
    ACTA DERMATO-VENEREOLOGICA, 2019, 99 (03) : 256 - 262
  • [25] Enzyme-linked immunosorbent assays for detection of anti-transcriptional intermediary factor-1 gamma and anti-Mi-2 autoantibodies in dermatomyositis
    Fujimoto, Manabu
    Murakami, Akihiro
    Kurei, Shunsuke
    Okiyama, Naoko
    Kawakami, Atsushi
    Mishima, Michiaki
    Sato, Shinji
    Seishima, Mariko
    Suda, Takafumi
    Mimori, Tsuneyo
    Takehara, Kazuhiko
    Kuwana, Masataka
    JOURNAL OF DERMATOLOGICAL SCIENCE, 2016, 84 (03) : 272 - 281
  • [26] Comment on: The temporal relationship between cancer and adult onset anti-transcriptional intermediary factor 1 antibody-positive dermatomyositis
    Korsten, Peter
    Seitz, Cornelia S.
    Sahlmann, Carsten O.
    Schmidt, Jens
    RHEUMATOLOGY, 2019, 58 (11) : 2071 - 2073
  • [27] Case of anti-transcriptional intermediary factor-1-positive dermatomyositis associated with breast cancer developing over 10 years
    Matsushita, Takashi
    Takehara, Kouhei
    Oishi, Kyosuke
    Maeda, Shintaro
    Hamaguchi, Yasuhito
    Ishikawa, Satoko
    Inokuchi, Masafumi
    Michiwa, Yoshio
    Takehara, Kazuhiko
    JOURNAL OF DERMATOLOGY, 2017, 44 (08): : 972 - 973
  • [28] Anti-transcription intermediary factor 1-gamma IgG2 isotype is associated with cancer in adult dermatomyositis: an ENMC multinational study
    Cordel, Nadege
    Dechelotte, Benoit
    Jouen, Fabienne
    Lamb, Janine A.
    Chinoy, Hector
    New, Paul
    Vencovsky, Jiri
    Mann, Herman
    Galindo-Feria, Angeles S.
    Dani, Lara
    Selva-O'Callaghan, Albert
    Werth, Victoria P.
    Ravishankar, Adarsh
    Landon-Cardinal, Oceane
    Tressieres, Benoit
    Boyer, Olivier
    RHEUMATOLOGY, 2023, 62 (04) : 1711 - 1715
  • [29] Pregnancy triggers the onset of anti-transcriptional intermediary factor 1γ antibody-positive dermatomyositis: a case series
    Oya, Kazumasa
    Inoue, Sae
    Saito, Akimasa
    Nakamura, Yoshiyuki
    Ishitsuka, Yosuke
    Fujisawa, Yasuhiro
    Watanabe, Rei
    Taguchi, Shijima
    Fujimoto, Manabu
    Okiyama, Naoko
    RHEUMATOLOGY, 2020, 59 (06) : 1450 - 1451
  • [30] Clinical significance of anti-transcriptional intermediary factor 1-γ antibody in patients with dermatomyositis: a monocentric cross-sectional study
    Yang, Huanhuan
    Yan, Tingting
    Zhang, Xin
    Sun, Wenjia
    Liu, Lei
    Du, Yan
    Xue, Jing
    CLINICAL RHEUMATOLOGY, 2022, 41 (08) : 2439 - 2448
12345